COMMUNIQUÉS West-GlobeNewswire

Unum Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on March 28, 2019 at 8:00 A.M. ET
21/03/2019
CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer using its [...]
Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality
21/03/2019
LAKE FOREST, Ill., March 21, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Dandy Dorado-Boladeres has been named as Executive Vice President of Global Quality, effective March 25, 2019. Mr. [...]
Algernon Pharmaceuticals Appoints Leading Liver Disease Expert Dr. Arun Sanyal to Its Medical and Scientific Advisory Board
21/03/2019
VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development [...]
ContraFect to Present at the Bacteriophage Therapy Summit
21/03/2019
YONKERS, N.Y., March 21, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics for [...]
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease
21/03/2019
Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and [...]
Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate
21/03/2019
Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment WAYNE, Pa., March 21, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) [...]
Exactus Appoints Emiliano Aloi as President
21/03/2019
DELRAY BEACH, Fla., March 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI; OTCQB:EXDID ), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has appointed [...]
Bavarian Nordic Announces Annual Report 2018
21/03/2019
Copenhagen, March 21, 2019 (GLOBE NEWSWIRE) -- COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Below is a summary of business progress, [...]
New Board starts reviewing the situation in Oasmia
21/03/2019
March 19th, the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The EGM was well represented with over a hundred participating shareholders and over 400 proxies. Jörgen [...]
Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
21/03/2019
LONDON, March 21, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Bavarian Nordic Awards Restricted Stock Units to Executive Management
21/03/2019
COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has awarded restricted stock units to members of the Executive Management. The Board of Directors of [...]
Neovacs to present the preclinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid at Keystone Congress
21/03/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRECLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID AT KEYSTONE CONGRESS: “Origins of Allergic Disease: Microbial, Epithelial [...]
Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde au Congrès Keystone
21/03/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES RESULTATS PR É CLINIQUES DE SON CANDIDAT VACCIN TH É RAPEUTIQUE IL-4/IL-13 KINO Ϊ DE AU CONGRÈS KEYSTONE : « Origines des maladies [...]
Addex to Participate in the BIOEurope Spring Conference
21/03/2019
Geneva, Switzerland, March 21, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer and Head of Discovery [...]
IBA annonce ses résultats annuels pour 2018
21/03/2019
Retour à la profitabilité au deuxième semestre 2018 Louvain-La-Neuve, Belgique, le 21 mars 2019 - IBA ( Ion Beam Applications SA , EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le [...]
IBA Reports Full Year 2018 Results
21/03/2019
Return to profitability in H2 Louvain-La-Neuve, Belgium, March 21, 2019 - IBA ( Ion Beam Applications SA , EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces [...]
Align University Training Institute Opens in Shanghai, China
21/03/2019
Align’s Second Training Facility in China Reflects Company’s Continued Commitment to Clinical Education SHANGHAI, China and SAN JOSE, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN), [...]
Genomics England and Cambridge Cancer Genomics (CCG.ai) announce immunotherapy partnership
21/03/2019
Partnership announced to improve access to, and the effectiveness of, immunotherapies in lung and colorectal cancers CAMBRIDGE, United Kingdom, March 20, 2019 (GLOBE NEWSWIRE) -- Genomics England, the Department of [...]
MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment for Atopic Dermatitis
21/03/2019
SAN DIEGO, March 20, 2019 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a clinical stage biotechnology company developing rationally designed microbiome therapeutics to treat the top five skin diseases, today announced [...]

Pages